vs

Side-by-side financial comparison of CATHAY GENERAL BANCORP (CATY) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

CATHAY GENERAL BANCORP is the larger business by last-quarter revenue ($222.8M vs $217.5M, roughly 1.0× Tilray Brands, Inc.). CATHAY GENERAL BANCORP runs the higher net margin — 653.4% vs -20.7%, a 674.1% gap on every dollar of revenue. On growth, CATHAY GENERAL BANCORP posted the faster year-over-year revenue change (19.5% vs 3.1%). Over the past eight quarters, CATHAY GENERAL BANCORP's revenue compounded faster (12.8% CAGR vs 7.5%).

Cathay General Bancorp is a U.S.-headquartered bank holding company that operates Cathay Bank, offering full-spectrum commercial and personal banking services. It primarily serves Asian American communities and small-to-medium enterprises across major U.S. states including California, New York and Texas, as well as select Asian markets, with products covering deposits, loans, and wealth management solutions.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

CATY vs TLRY — Head-to-Head

Bigger by revenue
CATY
CATY
1.0× larger
CATY
$222.8M
$217.5M
TLRY
Growing faster (revenue YoY)
CATY
CATY
+16.4% gap
CATY
19.5%
3.1%
TLRY
Higher net margin
CATY
CATY
674.1% more per $
CATY
653.4%
-20.7%
TLRY
Faster 2-yr revenue CAGR
CATY
CATY
Annualised
CATY
12.8%
7.5%
TLRY

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CATY
CATY
TLRY
TLRY
Revenue
$222.8M
$217.5M
Net Profit
$90.5M
$-44.9M
Gross Margin
26.4%
Operating Margin
50.9%
-10.2%
Net Margin
653.4%
-20.7%
Revenue YoY
19.5%
3.1%
Net Profit YoY
12.9%
47.4%
EPS (diluted)
$1.33
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CATY
CATY
TLRY
TLRY
Q4 25
$222.8M
$217.5M
Q3 25
$210.6M
$209.5M
Q2 25
$196.6M
$224.5M
Q1 25
$187.8M
$185.8M
Q4 24
$186.5M
$210.9M
Q3 24
$189.5M
$200.0M
Q2 24
$178.5M
$229.9M
Q1 24
$175.2M
$188.3M
Net Profit
CATY
CATY
TLRY
TLRY
Q4 25
$90.5M
$-44.9M
Q3 25
$77.7M
$-322.0K
Q2 25
$77.5M
$-1.3B
Q1 25
$69.5M
$-789.4M
Q4 24
$80.2M
$-85.3M
Q3 24
$67.5M
$-39.2M
Q2 24
$66.8M
$-31.7M
Q1 24
$71.4M
$-92.7M
Gross Margin
CATY
CATY
TLRY
TLRY
Q4 25
26.4%
Q3 25
27.4%
Q2 25
30.1%
Q1 25
28.0%
Q4 24
29.0%
Q3 24
29.8%
Q2 24
35.8%
Q1 24
26.2%
Operating Margin
CATY
CATY
TLRY
TLRY
Q4 25
50.9%
-10.2%
Q3 25
44.5%
1.0%
Q2 25
49.0%
-643.1%
Q1 25
46.1%
-409.0%
Q4 24
46.5%
-20.0%
Q3 24
41.2%
-18.3%
Q2 24
40.7%
-7.2%
Q1 24
45.7%
-43.6%
Net Margin
CATY
CATY
TLRY
TLRY
Q4 25
653.4%
-20.7%
Q3 25
36.9%
-0.2%
Q2 25
39.4%
-566.9%
Q1 25
37.0%
-424.9%
Q4 24
587.9%
-40.5%
Q3 24
35.6%
-19.6%
Q2 24
37.4%
-13.8%
Q1 24
40.8%
-49.2%
EPS (diluted)
CATY
CATY
TLRY
TLRY
Q4 25
$1.33
$-0.41
Q3 25
$1.13
$0.00
Q2 25
$1.10
$7.26
Q1 25
$0.98
$-8.69
Q4 24
$1.11
$-0.99
Q3 24
$0.94
$-0.04
Q2 24
$0.92
$-0.04
Q1 24
$0.98
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CATY
CATY
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$291.6M
Total DebtLower is stronger
$119.1M
Stockholders' EquityBook value
$2.9B
$1.6B
Total Assets
$24.2B
$2.1B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CATY
CATY
TLRY
TLRY
Q4 25
$291.6M
Q3 25
$264.8M
Q2 25
$256.4M
Q1 25
Q4 24
$252.2M
Q3 24
$280.1M
Q2 24
$260.5M
Q1 24
$225.9M
Total Debt
CATY
CATY
TLRY
TLRY
Q4 25
$119.1M
Q3 25
$119.1M
Q2 25
$119.1M
Q1 25
$119.1M
Q4 24
$119.1M
Q3 24
$119.1M
Q2 24
$119.1M
Q1 24
$119.1M
Stockholders' Equity
CATY
CATY
TLRY
TLRY
Q4 25
$2.9B
$1.6B
Q3 25
$2.9B
$1.5B
Q2 25
$2.9B
$1.5B
Q1 25
$2.9B
$2.7B
Q4 24
$2.8B
$3.5B
Q3 24
$2.8B
$3.5B
Q2 24
$2.8B
$3.4B
Q1 24
$2.8B
$3.4B
Total Assets
CATY
CATY
TLRY
TLRY
Q4 25
$24.2B
$2.1B
Q3 25
$24.1B
$2.1B
Q2 25
$23.7B
$2.1B
Q1 25
$23.2B
Q4 24
$23.1B
$4.2B
Q3 24
$23.3B
$4.3B
Q2 24
$23.2B
$4.2B
Q1 24
$23.4B
$4.2B
Debt / Equity
CATY
CATY
TLRY
TLRY
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×
Q1 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CATY
CATY
TLRY
TLRY
Operating Cash FlowLast quarter
$368.6M
$-8.5M
Free Cash FlowOCF − Capex
$363.7M
FCF MarginFCF / Revenue
163.2%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
4.07×
TTM Free Cash FlowTrailing 4 quarters
$672.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CATY
CATY
TLRY
TLRY
Q4 25
$368.6M
$-8.5M
Q3 25
$150.6M
$-1.3M
Q2 25
$64.0M
$-12.8M
Q1 25
$99.0M
$-5.8M
Q4 24
$329.2M
$-40.7M
Q3 24
$81.2M
$-35.3M
Q2 24
$72.9M
$30.7M
Q1 24
$88.2M
$-15.4M
Free Cash Flow
CATY
CATY
TLRY
TLRY
Q4 25
$363.7M
Q3 25
$150.1M
Q2 25
$62.7M
$-19.1M
Q1 25
$96.3M
$-20.2M
Q4 24
$325.5M
$-46.2M
Q3 24
$80.0M
$-42.0M
Q2 24
$72.4M
$21.0M
Q1 24
$87.3M
$-24.9M
FCF Margin
CATY
CATY
TLRY
TLRY
Q4 25
163.2%
Q3 25
71.3%
Q2 25
31.9%
-8.5%
Q1 25
51.2%
-10.9%
Q4 24
174.6%
-21.9%
Q3 24
42.2%
-21.0%
Q2 24
40.5%
9.1%
Q1 24
49.8%
-13.2%
Capex Intensity
CATY
CATY
TLRY
TLRY
Q4 25
2.2%
Q3 25
0.2%
Q2 25
0.6%
2.8%
Q1 25
1.4%
7.8%
Q4 24
1.9%
2.6%
Q3 24
0.6%
3.4%
Q2 24
0.3%
4.2%
Q1 24
0.5%
5.1%
Cash Conversion
CATY
CATY
TLRY
TLRY
Q4 25
4.07×
Q3 25
1.94×
Q2 25
0.83×
Q1 25
1.42×
Q4 24
4.10×
Q3 24
1.20×
Q2 24
1.09×
Q1 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CATY
CATY

Segment breakdown not available.

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons